Heron Therapeutics Stock News

When it comes to finding penny stocks to buy, there are plenty of things you'll need to make note of. Sure, broader stock market news trends don't directly influence cheap stocks.

Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secr

Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare wi

Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wa

Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secret

Are you looking for the best penny stocks to buy now? There are plenty to choose from, and how you approach the stock market today will help determine your strategy.

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.63 per share a year ago.

Wall Street is cheering a change in leadership at the company.

The stock has been rising since the company appointed a new CEO.

Monday, Heron announced the appointment of Craig Collard as Chief Executive Officer and Adam Morgan as Chairman. These two executives will replace outgoing CEO and Chairman Barry Quart.

Heron's cash position remains a concern. Zynrelef, the company's top-selling therapy for postoperative pain relief, had 2022 sales that were up 362%.

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. Silvergate Capital Corporation (NYSE: SI) climbed 48% to $1.67 on rumor suggesting a crypto exchange is trying to buy Sil

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spri

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants David Szekeres – Executive Vice President, Chief Operating Officer Barry Quart